| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |